Abstract:Objective: To investigate the effects of alendronate on expression levels of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa B ligand (RANKL) mRNAs in bone tissues of femoral head of rats receiving long-term glucocorticoid administration, and to explore the effect and mechanism of alendronate in preventing glucocorticoid-induced femoral head necrosis. Methods: Totally 30 healthy adult SD rats were randomly divided into 3 groups: glucocorticoid group, alendronate group and blank control group. The glucocorticoid group and alendronate group were treated by intramuscular injection of prednisolone, 12.5 mg/kg, two times per week, and rats in the alendronate group were intragastrically administered with alendronate, 5 mg/kg weight at the same time, one time per week. The control group was treated only by the same volume of intramuscularly injected sodium chloride. After 4 weeks' intervention, osteoporosis and osteonecrosis of left femoral head were detected by HE staining, the total RNA of right femoral head bone tissue was extracted and the expression levels of OPG and RANKL mRNAs were examined by real-time quantitative polymerase chain reaction (RTQ-PCR). Results: The mortality of rats was 10% (1/10), 10% (1/10) and 0 (0/10) in glucocorticoid, alendronate and control groups. The osteoporosis and necrosis rates of femoral bone head were 66.67% (6/9), 22. 22% (2/9) and 0 (0/10) in the three groups, respectively. The level of OPG mRNA expression was 0.96±0.16, 1.35±0.26 and 1.60±0.49 in glucocorticoid, alendronate and control groups, while the expression of RANKL mRNA was 3.33±1.04, 1.98±0.51 and 1.58±0.42. The level of OPG mRNA expression was lower in the glucocorticoid group than in the control group; the level of RANKL mRNA expression was increased in the glucocorticoid group, whose OPG /RANKL ratio decreased significantly (P<0.05). The alendronate and control groups did not differ significantly. Conlusion (1) Glucocorticoid significantly down-regulated the level of OPG mRNA expression and up-regulated RANKL mRNA expression, thus lowering OPG/RANKL ratio. (2) Alendronate prevents glucocorticoid-induced osteonecrosis of femoral head, which may be correlated to alendronate's counteracting with glucocorticiod in the regulation of expressions of OPG and RANKL mRNA.

Effect of antiresorptive drugs on cortical bone of cynomolgus monkeys by histomorphometrical analysis

Effect of antiresorptive agents (elcatonin and alendronate) on bone microdamage and remodeling in old cynomolgus monkeys vertebral bone

[The Study on the Inhibitive Effects of Recombinant Parathyroid Hormone (1-34) on Osteolysis in a Murine Calvarial Model Induced by Wear Particles].

The Effect of Alendronate on the Expression of Important Cell Factors in Osteoclasts

Effects of Local and Systemic Alendronate Delivery on Wear Debris-Induced Osteolysis in Vivo

Correlation analysis of positron emission tomography/computed tomography-magnetic resonance imaging of cannabinoid type 1 receptor in the lumbar spine and brain of aged osteoporosis female cynomolgus monkeys

Histological Effects of the Combined Administration of Eldecalcitol and a Parathyroid Hormone in the Metaphyseal Trabeculae of Ovariectomized Rats

The experiment in rat model with alendronate inhibiting abnormal alve olar bone resorption

[The Effect of Alendronate on Arterial Calcification in Rat Model].

Effect of alendronate on proliferation and osteogenic differentiation in MG-63 cells

Eldecalcitol, a vitamin D analog, reduces bone turnover and increases trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys

Pharmacodynamics of Cajanus cajan L. Extracts on Retinoic Acid Induced Osteoporosis in Rats

Effect of amylin on bone metabolic biochemical indexes in glucocorticoid-induced osteoporosis rats

Eldecalcitol improves mechanical strength of cortical bones by stimulating the periosteal bone formation in the senescence-accelerated SAM/P6 mice - a comparison with alfacalcidol

Short-term effect of zoledronic acid upon fracture resistance of the mandibular condyle and femoral head in an animal model

Effects of alendronate on MMPs/TIMPs in bone tissues of femoral head of rats applying glucocorticoid for long time

Effect of Osteoporosis Treatment Agents on the Cortical Bone Osteocyte Microenvironment in Adult Estrogen-Deficient, Osteopenic Rats.

Histomorphometry of Bone Microarchitecture in Rats Treated with Vitamin D and Bisphosphonate in the Management of Osteoporosis

Effectiveness of combined salmon calcitonin and aspirin therapy for osteoporosis in ovariectomized rats

Effects of alendronate on expression levels of OPG and RANKL mRNAs in bone tissues of femoral head of rats receiving long-term glucocorticoid administration

Effects of bisphosphonates on mandibular condyle of ovariectomized osteoporotic rats using micro-ct and histomorphometric analysis.